Research Article
2009 H1N1 Influenza Infection-Related Hospital Admissions: A Single Center Experience with Adult Patients in West Texas
Table 4
Treatment and outcomes of 2009 H1N1 influenza infection.
| Treatment and outcome | Total () | ICU () | Non-ICU () | value |
| Oseltamivir treatment | 28 (90%) | 14 (93%) | 14 (88%) | Ns | Days from onset to oseltamivir initiation | 3.42 (3.3) | 4.3 (3.8) | 2.6 (2.5) | Ns | Oseltamivir treatment within 48βhr of onset | 16 (57%) | 6 (43%) | 10 (71%) | Ns | Oseltamivir initiation before admission | 3 (11%) | 2 (14%) | 1 (7%) | Ns | Oseltamivir initiation on admission | 16 (57%) | 8 (57%) | 8 (57%) | Ns | Oseltamivir initiation within 48βhr of admission | 4 (14%) | 2 (14%) | 2 (14%) | Ns | Oseltamivir initiation after 48βhr of admission | 5 (18%) | 2 (14%) | 3 (21%) | Ns | Survive | 27 (87%) | 11 (73%) | 16 (100%) | 0.04 | Discharge to home | 20 (74%) | 6 (55%) | 14 (88%) | 0.009 | Discharge to long-term facility | 7 (26%) | 5 (45%) | 2 (13%) | Ns | ARDS | 8 (26%) | 8 (53%) | 0 | 0.001 | Septic shock | 7 (23%) | 7 (47%) | 0 | 0.002 | Secondary bacterial infections | 18 (58%) | 8 (53%) | 10 (63%) | Ns |
|
|
Ns: nonsignificant. for comparison of ICU and non-ICU patients by -test, test, or Fisherβs exact test. ARDS: acute respiratory distress syndrome.
|